RIMeL / IJLaM 2009; 5 (Suppl.)
102
Letture su invito Sessioni Plenarie SIBioC-SIMeL
Renal failure
V. Sepe ... 103
Standardization of the measurements of creatinine and new markers of renal insufficiency: an update
F. Ceriotti ... 104
Glomerular filtration rate measurement: from equations to report consensus
D. Giavarina ... 105
Urinary Albumin Excretion in chronic kidney disease: critical issues in measurement and reporting
M.S. Graziani ... 106
Biomarkers: state of the art and perspectives
G. Castaldo ... 107
Can we personalize drug therapy in colorectal cancer patients?
F. Innocenti ... 108
High Sensitivity C-reactive protein and other markers of cardiovascular inflammation: from bench to prove of efficacy
L.M. Biasucci ... 109
Non invasive diagnosis of gastrointestinal disorders: GastroPanel and Fibrotest
D. Basso ... 110
Clinical risk: from problem to opportunity
S. Dente ... 111
FMEA-FMECA: a risk management’s strument for critical processes
R. Locont ... 112
Pre-analytical phase: Risk Management and Risk Assessment in a Hospital Laboratory
S. Galmarini, G. Catanoso, G. Casiraghi ... 113
Risk management triggers in postanalytical phase
M. Morandini ... 114
Pharmacogenetics: promise or reality?
R.H.N. van Schaik ... 115
Pharmacogenetics and clinical oncology: a new deal for personalized therapies
S. Martinotti, S. Ursi, B. De Laurentiis, S. Matera, G. Vitullo, A. Allegrini, A. Tessitore, V. Flati, E. Toniato ... 116
Pharmacogenetics and diabetes
R. Testa, F. Olivieri ... 118
Pharmacogenetics of oral anticoagulant therapy
G. Lippi ... 119
